The Neonatal Thermoregulation Market Size was valued at USD 16.70 Billion in 2023. The Global Neonatal Thermoregulation industry is projected to grow from USD 19.60 Billion in 2024 to USD 24.30 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.23% during the forecast period (2024 - 2032). Neonatal thermoregulation market is expected to grow significantly over the forecast period. Thermoregulation is the ability to create equilibrium between heat production and heat loss in order to maintain body temperature within a certain normal range. The provision of a thermoneutral environment is an essential component of the immediate and long-term care of newborn infants. With the surge in the birth rates of newborns, the equipment used for blood sampling and monitoring the baby is steadily increasing.
For example, the Motherhood Hospitals chain launched virtual Neonatal Intensive Care Units (NICUs) in five locations across India in April 2023. Medical facilities continuously have to expand their service portfolio by incorporating new treatments so as to consolidate their market position.
In May 2023, Sibel Health received U.S.-FDA Clearance for its Anne One Newborn and Infant Monitoring Platform. It is a clinically graded wireless continuous monitoring solution designed uniquely for adults, infants and neonates.
Royal Philips unveiled its Philips Spectral Angio CT suite detector angio CT system with spectral CT imaging capabilities into a hybrid angio CT suite in September 2022. This will enable doctors to easily switch between two of the major imaging modalities in a single room for better treatment outcomes through minimally invasive procedures, thus facilitating innovation in this space, such as oncology, stroke or trauma care.
In July 2022, Royal Philips announced their AI-based systems and solutions while at the European Congress of Radiology. Through its portfolio of smart connected imaging systems and integrated radiology workflow solutions, Philips demonstrates how it can improve diagnostic confidence and clinical outcomes, reduce staff stress and burnout, increase patient engagement and access to quality care, and increase efficiency to reduce waste.
In April 2022 saw GE Healthcare unveiling the Giraffe Incubator Carestation. The Giraffe Carestation is an advanced neonatal facility that promotes natural healing while peace prevails. It allows parents’ presence at every stage thereby further cementing their relationship with the baby.
In April 2022, Natus Medical Incorporated stated that it had entered into a definitive agreement under which it would be acquired by one of its subsidiaries; ArchiMed’s valuation was $1.2 billion at the latest count.
In November 2019, Natus Medical Incorporated disclosed the acquisition of Babybe GmbH, including its patented remote mother-to-baby communication technology. This technology will augment Natus’s already established Newborn Care portfolio of products.
According to a data published by the Centers for Disease Control and Prevention in January 2017, there were 3,945,875 births in the US in 2017. This means birth rate in US in 2017 was 12.2 per 1000 population. Moreover, rising prevalence of diseases in neonates fuels the growth of the market.
The major players are involved in new product launches and strategic collaborations. For instance, in November 2016, Drägerwerk AG & Co. KGaA introduced IncuWarmer Babyleo TN500 which offers optimal thermoregulation in open care, closed care and transition to the premature baby.
However, stringent government regulation for product approval and possible side-effects for the neonates may hamper the market growth during the assessment period.
Segmentation:
The Neonatal thermoregulation market has been segmented into product type, modality, end-user, and region.The market, on the basis of product type, has been segmented into warmer, neonatal incubators, and neonatal cooling systems.The market, based on warmer, has been further segmented into radiant warmers and wall mount warmer.The market, by neonatal incubators, has been sub-segmented into intensive care incubator and transport incubator.The market, by modality, has been segmented into open and closed.
The market, by end-user, has been segmented into hospitals, pediatric and neonatal intensive care units, nursing homes, and others. The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Neonatal Thermoregulation Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European Market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The Neonatal Thermoregulation Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players:
GENERAL ELECTRIC COMPANY, Natus Medical Incorporated, Inspiration Healthcare Group plc., Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, International Biomedical, Ltd., Atom Medical Corporation, Fanem Ltd, and Novos Medical Systems are some of the key players in the neonatal thermoregulation market.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the Neonatal thermoregulation market owing to a well-developed healthcare sector. The involvement of government in creating awareness about the neonatal diseases also fuels the growth of the market. For instance, US government has programs like Screening Quality Assurance Programs and Heritable Disorders Program at Health Resources and Service Administration (HRSA). Thus, such initiatives and programs by the government as well as non-government organizations support the market growth.
Europe is expected to hold the second largest position in the Neonatal thermoregulation market. The market growth in this region is attributed to the availability of funds for research.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, and continuously developing economies, According to a report published by the International Journal of Social and Developmental Concerns in October 2017, in Malaysia, growth of the public primary as well as secondary care facilities has decreased in the past few years and it has not kept pace with the rapid urbanization. Thus, such factors restraint the growth of the market in this region. On the other hand, the Middle East & Africa has the least share of the market.
Market of Neonatal thermoregulation, by Product Type:
Market of Neonatal thermoregulation, by Modality:
Market of Neonatal thermoregulation, by End-user:
Neonatal thermoregulation market, by Region:
Market of Neonatal thermoregulation, by Key Players:
Intended Audience:
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
